Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 26, 2017 - Issue 8
Submit an article Journal homepage
330
Views
11
CrossRef citations to date
0
Altmetric
Review

Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma

Alice GuazzelliBiomedical Research Centre, School of Environment and Life Sciences, University of Salford, Salford, UKView further author information
,
Emyr BakkerBiomedical Research Centre, School of Environment and Life Sciences, University of Salford, Salford, UKView further author information
,
Kun TianBiomedical Research Centre, School of Environment and Life Sciences, University of Salford, Salford, UKView further author information
,
Constantinos DemonacosSchool of Health Sciences, University of Manchester, Manchester, UKView further author information
,
Marija Krstic-DemonacosBiomedical Research Centre, School of Environment and Life Sciences, University of Salford, Salford, UKView further author information
&
Luciano MuttiBiomedical Research Centre, School of Environment and Life Sciences, University of Salford, Salford, UKCorrespondence[email protected]
View further author information
Pages 933-944 | Received 25 Apr 2017, Accepted 03 Jul 2017, Published online: 12 Jul 2017

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Emanuela Cova, Laura Pandolfi, Miriam Colombo, Vanessa Frangipane, Simona Inghilleri, Monica Morosini, Simona Mrakic-Sposta, Sarah Moretti, Manuela Monti, Ymera Pignochino, Silvia Benvenuti, Davide Prosperi, Giulia Stella, Patrizia Morbini & Federica Meloni. (2019) Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study. International Journal of Nanomedicine 14, pages 773-785.
Read now
Alice Guazzelli, Parisa Meysami, Emyr Bakker, Ezio Bonanni, Constantinos Demonacos, Marija Krstic-Demonacos & Luciano Mutti. (2019) What can independent research for mesothelioma achieve to treat this orphan disease?. Expert Opinion on Investigational Drugs 28:8, pages 719-732.
Read now

Articles from other publishers (9)

Lamyae Nouiakh, Zineb Benbrahim, Karima Oualla, Abdelkrim Haita, Imane Ouafki, Soumia Berrad, Hayat Erraichi, Lamiae Amaadour, Samia Arif, Hind El Fatemi & Nawfel Mellas. (2021) Malignant pleural mesothelioma: Experience of the Medical Oncology Department of Hassan II Hospital in Fez, Morocco. Journal of Lung, Pulmonary & Respiratory Research 8:1, pages 6-11.
Crossref
Naoko Kumagai-Takei, Suni Lee, Hidenori Matsuzaki, Megumi Maeda, Nagisa Sada, Min Yu, Kei Yoshitome, Yasumitsu Nishimura & Takemi Otsuki. 2020. Allergy and Immunotoxicology in Occupational Health - The Next Step. Allergy and Immunotoxicology in Occupational Health - The Next Step 215 227 .
Olivia Sgarbura, Sophie Gourgou, Diego Tosi, Naoual Bakrin, Nabila Bouazza, Stéphanie Delaine, Hélène De Forges, Marc Pocard & François Quénet. (2019) MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma. Pleura and Peritoneum 4:2.
Crossref
Alice Guazzelli, Parisa Meysami, Emyr Bakker, Constantinos Demonacos, Antonio Giordano, Marija Krstic-Demonacos & Luciano Mutti. (2019) BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment. International Journal of Molecular Sciences 20:2, pages 429.
Crossref
Emyr Bakker, Alice Guazzelli, Constantinos Demonacos, Marija Krstic-Demonacos & Luciano Mutti. 2019. Malignant Pleural Mesothelioma. Malignant Pleural Mesothelioma 117 136 .
Kun Tian, Emyr Bakker, Michelle Hussain, Alice Guazzelli, Hasen Alhebshi, Parisa Meysami, Constantinos Demonacos, Jean-Marc Schwartz, Luciano Mutti & Marija Krstic-Demonacos. (2018) p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification. Journal of Translational Medicine 16:1.
Crossref
Robin Tranchant, Lisa Quetel, François Montagne, Julien De Wolf, Clement Meiller, Leanne De Koning, Françoise Le Pimpec-Barthes, Jessica Zucman-Rossi, Marie-Claude Jaurand & Didier Jean. (2018) Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma. Lung Cancer 126, pages 15-24.
Crossref
Marika Rossini, Paola Rizzo, Ilaria Bononi, Anthony Clementz, Roberto Ferrari, Fernanda Martini & Mauro G. Tognon. (2018) New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma. Frontiers in Oncology 8.
Crossref
Katalin Dobra & Anders Hjerpe. 2018. Serous Effusions. Serous Effusions 259 281 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.